Immunetics' drive to provide solutions that improve public health is fueled by science.
Funded by the National Institutes of Health (NIH) and in collaboration with researchers and clinicians at leading academic and medical institutions, we address critical issues in emerging diseases. Our scientists and research professionals are on the cutting-edge of diagnostic technology development.
Some of our recent research activities include:
SARS Diagnostic Test
Immunetics received one of the first National Institutes of Health grants for SARS research, which has supported the development of immunoassays using our patented QuickELISA™ technology. These tests will allow researchers to confirm an infection with the virus in humans as well as monitor its presence in animal reservoir populations.
Chagas' Disease Confirmatory Test
Chagas' disease is a serious and potentially fatal parasitic infection spread
by an insect vector, which can be transmitted through blood transfusions or organ transplants. While the disease is endemic in many tropical countries in Central and South America, it is spreading into the U.S. at an accelerating pace, often carried unknowingly by blood donors. Immunetics has been funded by the National Institutes of Health to develop a confirmatory test for Chagas' disease which will enable clinicians and blood centers to accurately screen patients or donors for the parasite.
Detection and Identification of Drug-Resistant Bacteria
With support from the National Institutes of Health, Immunetics is developing a molecular diagnostic test capable of rapid detection and identification of microbial pathogens, including drug-resistant strains such as MRSA and VRE, in blood and respiratory samples from patients with acute and life-threatening infections. This test will help clinicians to select more targeted and effective antibiotic therapy earlier in a patient's illness, greatly improving the likelihood of successful treatment.
We are committed to improving world health. Our research has resulted in quick and accurate diagnosis of some of the world's most virulent diseases including HIV, Anthrax, and Lyme disease. We are now pioneering an approach that will safeguard the world's blood supply from bacterial contamination.